In 1982, Taiwan launched the Good Manufacturing Practice (GMP) certification system for pharmaceutical companies. At the same time, Adimmune was considering a major change, deciding to specialize in human vaccine development.
1982 年，我國開始推行藥品及藥廠的優良作業規範（GMP）認證制度，與此同時，國光也思考轉型，決定朝專業的人用疫苗廠發展。